Logo-jpe

J Prev Epidemiol. 2022;7(1): e11. doi: 10.34172/jpe.2022.11

Epidemiology and Prevention

Molnupiravir; an effective drug in treating COVID-19?

Alireza Pouramini 1 ORCID, Fatemeh Kafi 1 ORCID, Shakiba Hassanzadeh 1 ORCID, Sanam Saeifar 2 * ORCID, Hamid Reza Jahantigh 3,4 ORCID

Cited by CrossRef: 1

1- Clark N, Taylor-Robinson A, Heimann K. Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?. Therapeutic Advances in Drug Safety. 2022;13:204209862211077 [Crossref]